Growth Trends in the Insulin Biosimilar Market, Forecast to 2034
05. Dezember 2024 10:28 ET
|
Research and Markets
Dublin, Dec. 05, 2024 (GLOBE NEWSWIRE) -- The "Insulin Biosimilar Market by Type of Insulin, by Mode of Administration, by Therapeutic Application, by Distribution Channel, and by Region" report has...
Australia Diabetes Market Forecasts and Company Analysis 2024-2032, Novo Nordisk, Eli Lilly, Roche, Abbott Laboratories, Insuletn, Dexcom, Medtronic, Ypsomed
25. November 2024 10:16 ET
|
Research and Markets
Dublin, Nov. 25, 2024 (GLOBE NEWSWIRE) -- The "Australia Diabetes Market Forecast Report by Type, End User and Company Analysis 2024-2032" report has been added to ResearchAndMarkets.com's...
Insulin Storage Devices Industry Forecast Report, 2025-2030 - Scarcity of Coverage in Insurance Policies Challenging the Market, Despite it Reaching $1.62 Billion by 2030
21. November 2024 06:36 ET
|
Research and Markets
Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Insulin Storage Devices Market by Product, Patient Type - Global Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering.The...
NLRP3 Protein Inhibitors Pipeline Research Report 2024: Therapeutic Assessment of 25+ Drugs by Product Type, Stage, Route of Administration, and Molecule Type
21. November 2024 04:21 ET
|
Research and Markets
Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "NLRP3 Protein Inhibitors - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.The report provides...
Insulin Delivery Pipeline Report 2024 - Stages of Development, Segments, Regulatory Path and Key Companies
12. November 2024 08:34 ET
|
Research and Markets
Dublin, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The "Insulin Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update"...
Spain Diabetes Market Report 2024-2032: A $1.32 Billion Industry Opportunity with Insights on Prevalence Trends, Demographical Breakup, Diagnosis and Treatment
17. Oktober 2024 04:12 ET
|
Research and Markets
Dublin, Oct. 17, 2024 (GLOBE NEWSWIRE) -- The "Spain Diabetes Market Report: 2024-2032" report has been added to ResearchAndMarkets.com's offering.The Spain diabetes market size reached US$ 947.9...
$49.3 Bn GLP-1 Markets 2024-2035 with Boehringer Ingelheim, Eli Lilly, Novo Nordisk Dominating
01. Oktober 2024 04:35 ET
|
Research and Markets
Dublin, Oct. 01, 2024 (GLOBE NEWSWIRE) -- The "GLP-1 Market: Industry Trends and Global Forecasts to 2035: Distribution by Type of Molecule, Active Compound Used, Type of GLP-1 Agonist Drugs, Type...
Type 2 Diabetes in the United States: A Review of 2023 - Key Insights into Treatment Awareness & Satisfaction
26. September 2024 04:19 ET
|
Research and Markets
Dublin, Sept. 26, 2024 (GLOBE NEWSWIRE) -- The "Type 2 Diabetes in the United States: A Review of 2023 - Key Insights into Treatment Awareness & Satisfaction" report has been added to ...
Rapid-Acting Insulin Market Expected to Reach $11.17 billion by 2032 | 2024 Research Report
09. September 2024 09:22 ET
|
Research and Markets
Dublin, Sept. 09, 2024 (GLOBE NEWSWIRE) -- The "Rapid Acting Insulin Market Report, Forecast by Product, Indication, Distribution Channel, Countries and Company Analysis 2024-2032" report has been...
embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes
03. September 2024 06:30 ET
|
Embecta Corp.
embecta has received 510(k) clearance from the FDA for its proprietary disposable insulin delivery system, a patch pump with a 300-unit insulin reservoir.